• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组组织型纤溶酶原激活剂活性B链的分离及初步鉴定

Isolation and preliminary characterisation of active B-chain of recombinant tissue-type plasminogen activator.

作者信息

Dodd I, Fears R, Robinson J H

出版信息

Thromb Haemost. 1986 Feb 28;55(1):94-7.

PMID:3085269
Abstract

Purified 2-chain recombinant tissue-type plasminogen activator (t-PA) was reduced under mild conditions - 10 mM dithiothreitol/5 degrees C/1.5 h - and the two chains were separated by chromatography on lysine Sepharose. The t-PA B chain was fully active as determined by its activity towards the chromogenic substrate S-2288 (H-D-ile-pro-arg p-nitroanilide). Analysis by sodium dodecyl sulphate polyacrylamide gel electrophoresis under reducing or non-reducing conditions revealed a single polypeptide at Mr = 35,000 or 29,000 respectively. In addition, under non-reducing conditions a fibrinolytic band at apparent Mr = 29,000 was present after fibrin zymography. The N-terminal sequence was confirmed as ile-lys-gly. The t-PA B chain had a specific amidolytic activity, using S-2288, of 170,000 to 210,000 SU/mg protein. (This compares to a specific activity of the native 2-chain t-PA of 170,000 SU/mg). It resembles urokinase-type plasminogen activator in its inability to be stimulated by fibrin and its dose response on human fibrin plates. However, t-PA B-chain was stimulated to almost the same extent as t-PA by poly-D-lysine. The isoelectric points, at pH 5.6 and 5.7, fall outside the range generally quoted for t-PA preparations (pH 7.8-8.8).

摘要

纯化的双链重组组织型纤溶酶原激活剂(t-PA)在温和条件下(10 mM二硫苏糖醇/5℃/1.5小时)进行还原,两条链通过赖氨酸琼脂糖凝胶柱层析分离。通过其对发色底物S-2288(H-D-异亮氨酸-脯氨酸-精氨酸对硝基苯胺)的活性测定,t-PA B链具有完全活性。在还原或非还原条件下进行十二烷基硫酸钠聚丙烯酰胺凝胶电泳分析,分别显示在Mr = 35,000或29,000处有一条单一多肽带。此外,在非还原条件下,纤维蛋白酶谱分析后在表观Mr = 29,000处出现一条纤维蛋白溶解带。N端序列经确认是异亮氨酸-赖氨酸-甘氨酸。t-PA B链使用S-2288时的比酰胺水解活性为170,000至210,000 SU/mg蛋白质。(相比之下,天然双链t-PA的比活性为170,000 SU/mg)。它在不能被纤维蛋白刺激以及在人纤维蛋白平板上的剂量反应方面类似于尿激酶型纤溶酶原激活剂。然而,聚-D-赖氨酸对t-PA B链的刺激程度与对t-PA的刺激程度几乎相同。其等电点在pH 5.6和5.7,不在通常报道的t-PA制剂的等电点范围内(pH 7.8 - 8.8)。

相似文献

1
Isolation and preliminary characterisation of active B-chain of recombinant tissue-type plasminogen activator.重组组织型纤溶酶原激活剂活性B链的分离及初步鉴定
Thromb Haemost. 1986 Feb 28;55(1):94-7.
2
Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator.由组织型纤溶酶原激活剂的NH2末端区域和尿激酶型纤溶酶原激活剂的COOH末端区域组成的嵌合纤溶酶原激活剂在纯化系统和人血浆中的抑制作用。
Thromb Haemost. 1988 Oct 31;60(2):247-50.
3
Isolation, identification and pharmacokinetic properties of human tissue-type plasminogen activator species: possible localisation of a clearance recognition site.人组织型纤溶酶原激活剂异构体的分离、鉴定及药代动力学特性:清除识别位点的可能定位
Thromb Haemost. 1988 Jun 16;59(3):523-8.
4
Characterization of plasminogen activator produced by an established cell line from human ovary.源自人卵巢的一个成熟细胞系所产生的纤溶酶原激活物的特性分析。
J Cell Physiol. 1988 Feb;134(2):253-60. doi: 10.1002/jcp.1041340211.
5
Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.组织型纤溶酶原激活剂(t-PA)、单链尿激酶型纤溶酶原激活剂(scu-PA)和尿激酶在体外血浆环境中对血凝块溶解不存在协同作用。
Thromb Haemost. 1986 Aug 20;56(1):35-9.
6
Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.通过在纤溶酶切割位点融合获得的嵌合型(组织型/尿激酶型)纤溶酶原激活剂的特性。
Thromb Haemost. 1993 May 3;69(5):466-72.
7
The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator.重组双链人组织型纤溶酶原激活剂催化结构域的2.3埃晶体结构。
J Mol Biol. 1996 Apr 26;258(1):117-35. doi: 10.1006/jmbi.1996.0238.
8
The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.通过生成包含与蛋白酶结构域相连的每个kringle的重组分子所揭示的kringle 1和kringle 2在重组组织型纤溶酶原激活剂酶学性质中的效应作用。
Arch Biochem Biophys. 1993 Jan;300(1):472-82. doi: 10.1006/abbi.1993.1064.
9
Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).大剂量组织型纤溶酶原激活剂及血浆半衰期延长的杂交纤溶酶原激活剂(K2tu-PA:CGP 42935)的溶栓和出血作用
Thromb Haemost. 1993 Aug 2;70(2):294-300.
10
Structure and function of human tissue-type plasminogen activator (t-PA).人组织型纤溶酶原激活剂(t-PA)的结构与功能
J Cell Biochem. 1986;32(3):169-78. doi: 10.1002/jcb.240320302.

引用本文的文献

1
Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin.组织型纤溶酶原激活物的指状结构域和kringle 2结构域参与纤维蛋白结合及纤维蛋白对其活性的刺激作用。
EMBO J. 1986 Dec 20;5(13):3525-30. doi: 10.1002/j.1460-2075.1986.tb04678.x.
2
Binding of plasminogen activators to fibrin: characterization and pharmacological consequences.纤溶酶原激活剂与纤维蛋白的结合:特性及药理学后果
Biochem J. 1989 Jul 15;261(2):313-24. doi: 10.1042/bj2610313.
3
Kinetic studies on the effect of heparin and fibrin on plasminogen activators.
肝素和纤维蛋白对纤溶酶原激活剂作用的动力学研究。
Biochem J. 1988 Jan 1;249(1):77-81. doi: 10.1042/bj2490077.
4
Kinetic studies on novel plasminogen activators. Demonstration of fibrin enhancement for hybrid enzymes comprising the A-chain of plasmin (Lys-78) and B-chain of tissue-type plasminogen activator (Ile-276) or urokinase (Ile-159).新型纤溶酶原激活剂的动力学研究。包含纤溶酶A链(Lys-78)与组织型纤溶酶原激活剂B链(Ile-276)或尿激酶B链(Ile-159)的杂合酶的纤维蛋白增强作用证明。
Biochem J. 1990 Mar 15;266(3):693-6. doi: 10.1042/bj2660693.